Validation of the 2019 American Society of Colposcopy and Cervical Pathology Online Cervical Cancer Screening Program via 9 Large-Cohort Data of Chinese Women
The 2019 US risk-based guideline works well with satisfied clinical sensitivity for CIN2+ and CIN3+ and seems applicable for cervical cancer screening in China.
Authors
- Hui Du (ORCID: https://orcid.org/0000-0002-4151-8127)
- Wenkui Dai (ORCID: https://orcid.org/0000-0002-9723-1416)
- Changzhong Li (ORCID: https://orcid.org/0000-0001-5654-1031)
- Qing Yang (ORCID: https://orcid.org/0000-0002-5068-6085)
- Di Wu (ORCID: https://orcid.org/0000-0003-2202-1921)
- Chun Wang (ORCID: https://orcid.org/0000-0001-7982-2004)
- Yi Zhang (ORCID: https://orcid.org/0009-0000-5564-1209)
- Xinfeng Qu (ORCID: https://orcid.org/0000-0002-2848-6263)
- Ruifang Wu (ORCID: https://orcid.org/0000-0002-1780-6540)
- J BELINSON
- Chunlei Guo
Institutions
- Cleveland Clinic (US)
- Hong Kong University of Science and Technology (HK)
- Peking University Shenzhen Hospital (CN)
Publication Details
- Journal
- Journal of Lower Genital Tract Disease
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1097/lgt.0000000000000852
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39